Moran ben David
Director/Board Member at Immunyx Pharma Ltd.
Moran ben David active positions
| Companies | Position | Start | End |
|---|---|---|---|
Immunyx Pharma Ltd.
 Immunyx Pharma Ltd. Pharmaceuticals: GenericHealth Technology Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation. | Director/Board Member | 2021-03-31 | - |
Van Leer Xenia Ventures
 Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel. | Corporate Officer/Principal | 2019-06-30 | - |
Career history of Moran ben David
Former positions of Moran ben David
| Companies | Position | Start | End |
|---|---|---|---|
| GSK PLC | Director/Board Member | 2015-03-31 | 2017-05-01 |
| NOVARTIS AG | Director/Board Member | 2013-12-31 | 2016-08-01 |
Training of Moran ben David
| Tel-Aviv University | Undergraduate Degree |
| Questrom School of Business | Masters Business Admin |
Statistics
International
| Israel | 3 |
| United States | 3 |
| Switzerland | 2 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| GSK PLC | Health Technology |
| Private companies | 2 |
|---|---|
Van Leer Xenia Ventures
Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel. | Finance |
Immunyx Pharma Ltd.
Immunyx Pharma Ltd. Pharmaceuticals: GenericHealth Technology Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Moran ben David
- Experience
